Zakirova A N, Mingazetdinova L N, Kamilov F Kh, Lankin V Z, Lebedev A V, Konovalova G G
Ter Arkh. 1994;66(9):24-8.
Lipid peroxidation, antioxidant system and hemorheology were studied in the course of ceruloplasmin treatment given to 47 patients with ischemic heart disease (IHD). Coupled changes in the above systems seem to be involved in pathogenesis of IHD variants. Ceruloplasmin effectively inhibits lipid peroxidation, corrects hemorheological disorders, improves IHD running.
对47例缺血性心脏病（IHD）患者进行铜蓝蛋白治疗，期间研究了脂质过氧化、抗氧化系统和血液流变学。上述系统的相关变化似乎参与了缺血性心脏病不同类型的发病机制。铜蓝蛋白能有效抑制脂质过氧化，纠正血液流变学紊乱，改善缺血性心脏病病情。
